21st North Company Profile (OTCMKTS:ULGX)

About 21st North

21st North logo21st North Inc., formerly Urologix Inc., was engaged in developing, manufacturing, marketing and distributing medical products. The Company offered its products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia (BPH). The Company has no operations. The Company intends to dissolve.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: OTCMKTS
  • Symbol: ULGX
  • CUSIP:
Key Metrics:
  • Previous Close: $0.00
  • 50 Day Moving Average: $
  • 200 Day Moving Average: $
  • 52-Week Range: $21,282,000.00 - $0.00
  • Trailing P/E Ratio:
  • Foreward P/E Ratio: -0.01
  • P/E Growth:
  • Market Cap: $
  • Outstanding Shares: 21,282,000
  • Beta: 4.29
Additional Links:
Companies Related to 21st North:

Analyst Ratings

Consensus Ratings for 21st North (OTCMKTS:ULGX) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for 21st North (OTCMKTS:ULGX)
No equities research coverage for this company has been tracked by MarketBeat.com


Earnings History for 21st North (OTCMKTS:ULGX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/5/2015Q215($0.02)$3.80 million$3.10 millionViewListenView Earnings Details
8/19/2014Q4 14($0.17)$3.29 millionViewN/AView Earnings Details
2/4/2014Q4($0.05)ViewListenView Earnings Details
11/14/2012Q113($0.06)($0.05)$4.48 million$4.00 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for 21st North (OTCMKTS:ULGX)
Current Year EPS Consensus Estimate: $-0.2100 EPS
Next Year EPS Consensus Estimate: $-0.2300 EPS


Dividend History for 21st North (OTCMKTS:ULGX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for 21st North (OTCMKTS:ULGX)
Insider Ownership Percentage: 8.50%
Institutional Ownership Percentage: 0.09%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/26/2013Gregory FluetCEOBuy17,500$0.31$5,425.00View SEC Filing  
7/12/2013Mitchell DannDirectorBuy20,000$0.30$6,000.00View SEC Filing  
7/10/2013Gregory FluetCEOBuy25,000$0.24$6,000.00View SEC Filing  
7/9/2013Lisa A AckermannEVPBuy18,500$0.24$4,440.00View SEC Filing  
7/8/2013Gregory FluetCEOBuy66,400$0.19$12,616.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for 21st North (OTCMKTS:ULGX)
finance.yahoo.com logo21st North Inc. (formerly known as Urologix, Inc.) Announces Expected Timeline for Administrative Dissolution of the Company (OTCMKTS:ULGX)
finance.yahoo.com - April 25 at 3:05 PM
finance.yahoo.com logoUrologix Announces Sale of Operating Assets to Private Company Buyer (OTCMKTS:ULGX)
finance.yahoo.com - February 2 at 4:05 PM
finance.yahoo.com logoUROLOGIX INC Financials (OTCMKTS:ULGX)
finance.yahoo.com - December 8 at 1:11 PM
finance.yahoo.com logoEdited Transcript of ULGX earnings conference call or presentation 12-May-15 9:00pm GMT (OTCMKTS:ULGX)
finance.yahoo.com - July 16 at 7:03 PM
biz.yahoo.com logoUROLOGIX INC Files SEC form 8-K, Other Events (OTCMKTS:ULGX)
biz.yahoo.com - July 10 at 4:01 PM
noodls.com logoUrologix Announces SEC Deregistration (OTCMKTS:ULGX)
www.noodls.com - July 9 at 4:21 PM
noodls.com logoCosts for In-Office BPH Therapies Presented at the AUA 2015 Annual Meeting in New Orleans (OTCMKTS:ULGX)
www.noodls.com - May 21 at 4:33 PM
biz.yahoo.com logoUROLOGIX INC Files SEC form 10-Q, Quarterly Report (OTCMKTS:ULGX)
biz.yahoo.com - May 14 at 4:16 PM
biz.yahoo.com logoUROLOGIX INC Files SEC form 8-K, Results of Operations and Financial Condition (OTCMKTS:ULGX)
biz.yahoo.com - May 13 at 7:09 AM
noodls.com logoUrologix Products Featured in Cost-Effectiveness Research to be Presented at Upcoming Industry Meeting in New Orleans (OTCMKTS:ULGX)
www.noodls.com - May 12 at 4:46 PM
noodls.com logoUrologix Reports Third Quarter Fiscal Year 2015 Results (OTCMKTS:ULGX)
www.noodls.com - May 12 at 4:46 PM
noodls.com logoUrologix to Host Its Fiscal Year 2015 Third Quarter Conference Call (OTCMKTS:ULGX)
www.noodls.com - May 5 at 4:33 PM
biz.yahoo.com logoUROLOGIX INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits (OTCMKTS:ULGX)
biz.yahoo.com - March 23 at 2:02 PM
noodls.com logoUrologix Announces Hiring of Chief Financial Officer (OTCMKTS:ULGX)
www.noodls.com - March 23 at 9:11 AM
biz.yahoo.com logoUROLOGIX INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events (OTCMKTS:ULGX)
biz.yahoo.com - January 12 at 8:10 AM


What is 21st North's stock symbol?

21st North trades on the OTCMKTS under the ticker symbol "ULGX."

When will 21st North announce their earnings?

21st North is scheduled to release their next quarterly earnings announcement on Thursday, August, 20th 2015.

How do I buy 21st North stock?

Shares of 21st North can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of 21st North stock cost?

One share of 21st North stock can currently be purchased for approximately $0.00.

21st North (OTCMKTS:ULGX) Chart for Sunday, February, 26, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for 21st North (OTCMKTS:ULGX)

Earnings History Chart

Earnings by Quarter for 21st North (OTCMKTS:ULGX)

Dividend History Chart

Dividend Payments by Quarter for 21st North (OTCMKTS:ULGX)

Last Updated on 2/26/2017 by MarketBeat.com Staff